Canada markets open in 3 hours 27 minutes

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS)

Shanghai - Shanghai Delayed Price. Currency in CNY
Add to watchlist
68.28-0.22 (-0.32%)
At close: 03:00PM CST
Currency in CNY

Valuation Measures4

Market Cap (intraday) 86.59B
Enterprise Value 81.09B
Trailing P/E 682.80
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)25.48
Price/Book (mrq)6.76
Enterprise Value/Revenue 24.02
Enterprise Value/EBITDA 879.88

Trading Information

Stock Price History

Beta (5Y Monthly) 2.32
52-Week Change 3-6.45%
S&P500 52-Week Change 323.57%
52 Week High 388.00
52 Week Low 340.14
50-Day Moving Average 369.73
200-Day Moving Average 359.50

Share Statistics

Avg Vol (3 month) 310.22M
Avg Vol (10 day) 36.85M
Shares Outstanding 51.27B
Implied Shares Outstanding 61.27B
Float 8256.72M
% Held by Insiders 181.77%
% Held by Institutions 13.28%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 41
Forward Annual Dividend Yield 41.46%
Trailing Annual Dividend Rate 30.32
Trailing Annual Dividend Yield 30.47%
5 Year Average Dividend Yield 4N/A
Payout Ratio 41,000.00%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 05, 2023
Last Split Factor 21.4:1
Last Split Date 3Jun 05, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 3.80%
Operating Margin (ttm)9.67%

Management Effectiveness

Return on Assets (ttm)0.09%
Return on Equity (ttm)0.92%

Income Statement

Revenue (ttm)3.38B
Revenue Per Share (ttm)2.68
Quarterly Revenue Growth (yoy)-73.90%
Gross Profit (ttm)N/A
EBITDA 250.31M
Net Income Avi to Common (ttm)128.47M
Diluted EPS (ttm)0.10
Quarterly Earnings Growth (yoy)-89.90%

Balance Sheet

Total Cash (mrq)6.13B
Total Cash Per Share (mrq)4.83
Total Debt (mrq)331.63M
Total Debt/Equity (mrq)2.55%
Current Ratio (mrq)4.20
Book Value Per Share (mrq)10.11

Cash Flow Statement

Operating Cash Flow (ttm)1.86B
Levered Free Cash Flow (ttm)980.72M